Latest News in the pharma Industry

Market News

Enamine expands collaboration with Europe’s largest biopharmaceutical company

Enamine expands collaboration with Europe’s largest biopharmaceutical company

23 Jan 2017

Extends multi-year agreement in drug discovery with focus on cardiovascular and central nervous system disorders, immunology, infectious diseases and oncology.

Read more 
Irvine Scientific introduces PRIME-XV T cell CDM for immunotherapy applications

Irvine Scientific introduces PRIME-XV T cell CDM for immunotherapy applications

23 Jan 2017

The first chemically-defined, animal component-free, cell culture medium for T cells.

Read more 
Endo agreement to resolve FTE investigation and litigation

Endo agreement to resolve FTE investigation and litigation

23 Jan 2017

No admission of wrongdoing, No monetary payment by Endo.

Read more 
BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation

BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation

22 Jan 2017

Merck to pay BMS and Ono royalties on global sales of Keytruda through 2026, and lump-sum payment of $625 million.

Read more 
Mylan acquires Cold-EEZE brand to further expand OTC business

Mylan acquires Cold-EEZE brand to further expand OTC business

22 Jan 2017

Cold-EEZE will become Mylan's largest US OTC brand franchise.

Read more 
Lilly to acquire CoLucid for $960 million

Lilly to acquire CoLucid for $960 million

18 Jan 2017

Deal will enhance Lilly's existing pain management portfolio for migraine and adds potential near-term launch to its late-stage pipeline.

Read more 
Hikma receives FDA approval for generic equivalent to Xyrem

Hikma receives FDA approval for generic equivalent to Xyrem

18 Jan 2017

Company's subsidiary currently involved in patent litigation concerning this product.

Read more 
Merck opens production facility exclusively for meglumine

Merck opens production facility exclusively for meglumine

17 Jan 2017

Regulatory compliant, FDA-audited facility based in Mollet des Vallès, Spain.

Read more 
Biogen agrees to pay Forward Pharma $1.25 billion

Biogen agrees to pay Forward Pharma $1.25 billion

17 Jan 2017

The settlement and license agreement will strengthen Biogen's IP for leading oral therapy for multiple sclerosis.

Read more 
Suliqua approved in the EU for the treatment of adults with type 2 diabetes

Suliqua approved in the EU for the treatment of adults with type 2 diabetes

17 Jan 2017

Suliqua will be delivered in two pre-filled SoloSTAR pens, providing different dosing options that may help answer individual market and patient insulin needs.

Read more 
MicroJect Reactor technology to take centre stage in new partnership

MicroJect Reactor technology to take centre stage in new partnership

16 Jan 2017

leon nanodrugs' MJR technology offers reformulation options that address API solubility issues.

Read more 
A-Skin secures patent for groundbreaking skin engineering therapy

A-Skin secures patent for groundbreaking skin engineering therapy

16 Jan 2017

WHF therapy can be directly applied on a wound to stimulate the natural human wound healing process.

Read more